In 2009 a consensus between the American Heart Association AHA and renowned international organizations International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung and Blood Institute, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity agreed to define the metabolic syndrome as a clinical condition characterized by the presence of at least three of the following factors: a large abdominal circumference; b increased triglycerides >150 mg/dL; c reduced HDL <40 mg/ dL in females and <50 in males; d high blood pressure >130/85 mmHg, and e fasting glucose >100 mg/dL. Among these factors, the abdominal circumference measurement was the only factor requiring special considerations, considering that such measurement could vary significantly, depending on the population.
En 2009 un consenso entre la American Heart Association AHA y reconocidas entidades internacionales International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung and Blood Institute, World Heart Federation, Intenational Atherosclerosis Society e International Association for the Study of Obesity acordó definir el síndrome metabólico como una entidad clínica caracterizada por la presencia de por lo menos tres de los siguientes factores: a perímetro abdominal aumentado; b triglicéridos aumentados > 150 mg/dl; c cifras de HDL bajas < 40 mg/dl en mujeres y < 50 en varones; d hipertensión arterial > 130/85 mmHg, y e glucemia preprandial > 100 mg/dl. De estos factores, el perímetro abdominal es el único factor que necesitó consideraciones especiales de medición teniendo en cuenta que dicha medida podría variar significativamente dependiendo de la población.